Source: Annual Congress 2005 - Gene expression, receptors and markers in lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
C. Mascaux, A. Haller, B. Martin, F. Feoli, V. Ninane, J. P. Sculier (Brussels, Belgium). Early lung carcinogenesis: MDM2 expression in bronchial preneoplastic lesions and its correlation with p53. Eur Respir J 2005; 26: Suppl. 49, 2928

Member's Comments

No comment yet.

Related content which might interest you: The expression of Ki-67 in preneoplastic and early neoplastic bronchial lesions Source: Eur Respir J 2002; 20: Suppl. 38, 229s Year: 2002 The expression of Ki-67 in preneoplastic and early neoplastic bronchial lesions Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001 Evolution of microRNA expression during human bronchial squamous carcinogenesis Source: Eur Respir J 2009; 33: 352-359 Year: 2009 Combined expression of p53, Bcl-2 and p21WAF-1 proteins in endobronchial biopsies may be associated with lung cancer prognosis Source: Eur Respir J 2001; 18: Suppl. 33, 230s Year: 2001 Angiogenesis in preinvasive, early invasive bronchial lesions and micropapillomatosis and correlation with EGF-R expression Source: Annual Congress 2006 - Lung cancer biology and chemosensitivity Year: 2006 Correlation of P53 and CerbB-2 expression in the diagnostic biopsies and the corresponding resected tumors in non small cell lung caner Source: Eur Respir J 2004; 24: Suppl. 48, 43s Year: 2004 Polymorphism in GSTM1, GSTT1, p53 and CCR5 genes and lung cancer progression: relation to p53 and Ki-67 protein expression in tumors of non-small cell lung cancer patients Source: Eur Respir J 2006; 28: Suppl. 50, 810s Year: 2006 Mutant P53 expression in squamous cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 72s Year: 2002 COX-2 expression during early lung squamous cell carcinomas oncogenesis Source: Eur Respir J 2005; 26: Suppl. 49, 456s Year: 2005 Aberrant methylation of p16 tumour suppresor gene and DAP kinase in nonsmall cell lung carcinomas Source: Eur Respir J 2001; 18: Suppl. 33, 233s Year: 2001 Lung cancer: immunopathology Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=48 Year: 2001 Coexpression of Ki-67 and PCNA in precancer lesions in chronic diffuse lung diseases (CDLD) as a predictor of their malignant potential Source: Eur Respir J 2001; 18: Suppl. 33, 19s Year: 2001 The role of P53 tumor suppressor gene mutations in early diagnosis of lung cancer among patients with solitary pulmonary nodule Source: Annual Congress 2009 - Pathogenesis of lung cancer Year: 2009 Expression of survivin and p53 protein in pulmonary tumours Source: Annual Congress 2011 - Progress in pathology of lung cancer Year: 2011 The association of p53 and p21 expression with clinicopathological parameters and prognosis in non-small cell lung cancer Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010 p16INK4a promoter hypermethylation in tissue, blood, and sputum from non-small cell lung cancer and pulmonary inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 813s Year: 2006 Loss of polymeric immunoglobulin receptor expression is associated with lung tumourigenesis Source: Eur Respir J 2012; 39: 1171-1180 Year: 2012 COPD-like inflammation drives the progression of K-ras induced early cancerous lesions Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 Correlation of miR-422a, miR-21 and miR-155 analysis with hMSH2 and hMLH1 mRNA expression profiles in non-small cell lung carcinomas and their adjacent normal tissues Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013 Studies on clinical significance and relationship with PI and gene protein expression of p16, Rb and Cyclin-D1 in lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 230s Year: 2002